Table IV.
All PACE patients (N = 182,116). | Patients whose primary pharmacy was among the top 5 pharmacies in Pennsylvania (N =75,413). | |||
---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |
C statistic = 0.595 | C statistic = 0.597 | |||
Pseudo R2 = 0.0291 | Pseudo R2 = 0.0304 | |||
Odds ratio (95% CI) | ||||
Baseline covariates assessed in 2004 | ||||
Age on January 1, 2005, y | ||||
65–74 | Reference | Reference | Reference | Reference |
75–84 | 0.96 (0.94–0.99) | 0.99 (0.96–1.01) | 0.92 (0.88–0.96) | 0.95 (0.92–0.99) |
≥85 | 1.05 (1.02–1.09) | 1.09 (1.06–1.13) | 0.90 (0.86–0.95) | 0.95 (0.91–1.00) |
Female | 1.06 (1.03–1.09) | 1.00 (1.00–1.00) | 1.05 (1.00–1.09) | 1.00 (1.00–1.00) |
White race | 0.64 (0.61–0.66) | 1.00 (1.00–1.00) | 0.64 (0.61–0.67) | 1.00 (1.00–1.00) |
Residing in an urban zip code | ||||
1.27 (1.24–1.30) | 1.00 (1.00–1.00) | 1.34 (1.30–1.39) | 1.00 (1.00–1.00) | |
Unique medications in 2004 | ||||
≤5 | Reference | Reference | Reference | Reference |
6–9 | 0.70 (0.68–0.71) | 1.01 (0.98–1.05) | 0.75 (0.72–0.79) | 1.03 (0.98–1.08) |
10–14 | 0.83 (0.80–0.85) | 1.36 (1.30–1.42) | 0.90 (0.86–0.95) | 1.39 (1.31–1.48) |
≥15 Medications | 1.10 (1.06–1.14) | 1.92 (1.82–2.03) | 1.25 (1.19–1.33) | 2.07 (1.91–2.24) |
Prescriptions filled in 2004 | ||||
<25 | Reference | Reference | Reference | Reference |
25–49 | 0.55 (0.54–0.57) | 0.51 (0.49–0.53) | 0.57 (0.54–0.59) | 0.52 (0.50–0.55) |
49–74 | 0.62 (0.60–0.64) | 0.50 (0.48–0.52) | 0.64 (0.61–0.67) | 0.52 (0.49–0.55) |
≥75 | 0.71 (0.69–0.74) | 0.47 (0.45–0.49) | 0.73 (0.69–0.77) | 0.48 (0.44–0.51) |
Includes only data available to the primary pharmacy.